This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Campbell, J R Articles by Edwards, M S Search for Related Content PubMed PubMed Citation Articles by Campbell, J R Articles by Edwards, M S

 Previous Article  |  Next Article 

Infect Immun. 1992 November; 60(11): 4558-4562

Influence of serotype of group B streptococci on C3 degradation.

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.

ABSTRACT

Serotype III strains of group B streptococci (GBS) are isolated from the majority of young infants with bacteremia or meningitis. We hypothesized that serotype-associated differences in structure of the type-specific capsular polysaccharide or the presence of c protein would influence the extent to which C3 degradation occurs on GBS and that type-specific antibody would alter C3 deposition or degradation patterns. When clinical isolates of GBS representing serotypes Ia, Ib/c, II (with or without c protein) and III were employed with hypogammaglobulinemic serum as an opsonic source, a remarkable similarity was observed in patterns of C3 deposition and degradation for each of the four GBS serotypes and between strains with or without c protein. Both C3b and iC3b were detected by 5 min and throughout a 90-min opsonization interval. Less deposition occurred at 5 min on serotypes Ia and Ib/c than on types II and III GBS. Minimal degradation to C3d or smaller fragments was observed. Type-specific antibody facilitated C3b deposition on GBS and C3b degradation to iC3b early in opsonization. Possibly, accessibility of C3 fragments to neutrophil receptors, rather than the extent to which the surface permits C3 degradation, accounts for differential virulence among GBS serotypes.

This article has been cited by other articles:

• Levy, O., Jean-Jacques, R. M., Cywes, C., Sisson, R. B., Zarember, K. A., Godowski, P. J., Christianson, J. L., Guttormsen, H.-K., Carroll, M. C., Nicholson-Weller, A., Wessels, M. R. (2003). Critical Role of the Complement System in Group B Streptococcus-Induced Tumor Necrosis Factor Alpha Release. Infect. Immun. 71: 6344-6353 [Abstract] [Full Text]